US Stocks
/
Roivant Sciences Ltd. Share Price

Roivant Sciences Ltd. Share Price

NASDAQ: ROIV | Large Cap
$34.89
+$0.66 (1.94%) Last updated on 09 Oct, 2026 | 22:16 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Roivant Sciences Ltd. Stock Performance

Open
$34.27
Prev. Close
$34.23
Circuit Range
N/A
Day Range
$34.22 - $34.91
Year Range
$15.90 - $42.49
Volume
1,12,564
Average Traded
$34.64

Roivant Sciences Ltd. Share Price Today

As of 9 October 2026, Roivant Sciences Ltd.'s share price is $34.89. The stock opened at $34.27, compared to its previous close of $34.23. During today's trading session, Roivant Sciences Ltd.'s share price traded between $34.22 and $34.91, with an average price of $34.56. Over the past 52 weeks, the stock has recorded a high of $42.49 and a low of $15.90. In terms of performance, Roivant Sciences Ltd.'s share price has risen by 22.29% over the last six months and is up 74.58% on a year-on-year basis.

Roivant Sciences Ltd. Share Price Chart

$34.22$34.91
L
Show Current Price
H

Roivant Sciences Ltd. Stock Fundamentals & Key Indicators

Market Cap
$25.31B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.37
Revenue (TTM)
$8.26B
Return On Equity (TTM)
-6.29%
Profit Margin
-3629.18%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-67.23%

Roivant Sciences Ltd. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$1.57$2.00$2.52$1.44
Net Profit-$113.52-$265.89$302.99-$189.84
Net Profit Margin-7230.57%-13294.50%12023.41%-13183.33%
Income ChangeN/A-134.22%213.95%-162.66%

Roivant Sciences Ltd. Annual Profit & Loss

All figures in USD

Particulars2023202420252026
Revenue$31.53$32.71$29.05$8.26
Net Profit-$1009.03$4348.93-$171.98-$299.77
Net Profit Margin-3200.22%13295.41%-592.01%-3629.18%
Income ChangeN/A531.00%-103.95%-74.31%

About Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Roivant Sciences Ltd. Historical Returns

MonthOpenCloseChange %
Oct 2026
$36.24
$34.86
-4.78%
Sep 2026
$34.63
$36.61
-2.56%
Aug 2026
$33.18
$37.57
+10.81%
Jul 2026
$35.33
$33.91
-4.22%
Jun 2026
$29.36
$35.40
+17.98%
May 2026
$28.75
$30.00
+5.17%
Apr 2026
$28.05
$28.53
+2.96%
Mar 2026
$28.64
$27.71
-4.27%
Feb 2026
$21.48
$28.95
+33.94%
Jan 2026
$21.67
$21.61
-0.37%
Dec 2025
$20.55
$21.69
+4.18%
Nov 2025
$19.93
$20.82
+4.18%

ROIV Share Price FAQs

What is Roivant Sciences Ltd. share price today?

chevron-up
Roivant Sciences Ltd. share price today is $34.89 as on October 9, 2026 at 10:16 pm IST.

What is the 52 week high and 52 week low of Roivant Sciences Ltd. stock?

chevron-up
The 52 week high of Roivant Sciences Ltd. stock is $42.49, while the 52 week low is $15.90 as of 9 Oct '26.

What is ROIV's market capitalisation today?

chevron-up
ROIV market capitalisation is $25.31B as of October 9, 2026, at 10:16 pm IST.

What is ROIV's net income for the last quarter?

chevron-up
ROIV's net income for the last quarter is -189.84B USD.

What is the 5 year returns of ROIV?

chevron-up
The 5 year returns of ROIV is 339.42% as on 9 Oct '26.

What is the high & low stock price of ROIV today?

chevron-up
ROIV stock price hit a high of $34.91 and low of $34.22 as of 9 Oct '26.

Can I buy ROIV shares in India?

chevron-up
Yes. You can buy ROIV in India by opening an international trading account.